Leanna J. Standish, Cynthia A. Wenner, Erin S. Sweet, Carly Bridge, Ana Nelson, Mark Martzen, Jeffrey Novack, Carolyn Torkelson
Abstract
Data from multiple epidemiologic and clinical studies on immune effects of conventional cancer treatment and the clinical benefits of polysaccharide immune therapy suggest that immune function has a role in breast cancer prevention. Immune therapy utilizing the polysaccharide constituents of Trametes versicolor (Tv) as concurrent adjuvant cancer therapy may be warranted as part of a comprehensive cancer treatment and secondary prevention strategy.
Reference:
J Soc Integr Oncol. 2008 Summer; 6(3): 122–128
